SEC Form 4 · accession 0000899243-16-021678
OCULAR THERAPEUTIX, INC · OCUL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard L Lindstrom M.D.
Director
Period of report
Jun 2, 2016
Accepted (ET)
Jun 3, 2016 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393434
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $12.05 | Jun 2, 2016 | A | 13,500 | A | — | Jun 1, 2026 | Common Stock | 13,500 | 13,500 | D |
Explanation of responses
- F1Vests with respect to 100% of the securities on the first anniversary of the grant date.